MY142756A - Crystalline composition containing escitalopram. - Google Patents

Crystalline composition containing escitalopram.

Info

Publication number
MY142756A
MY142756A MYPI20050870A MYPI20050870A MY142756A MY 142756 A MY142756 A MY 142756A MY PI20050870 A MYPI20050870 A MY PI20050870A MY PI20050870 A MYPI20050870 A MY PI20050870A MY 142756 A MY142756 A MY 142756A
Authority
MY
Malaysia
Prior art keywords
escitalopram
crystalline particles
composition containing
escitalopram oxalate
crystalline composition
Prior art date
Application number
MYPI20050870A
Other languages
English (en)
Inventor
Kim Boejstrup Jensen
Rikke Eva Humble
Ken Liljegren
Troels Volsgaard Christensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MY142756A publication Critical patent/MY142756A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MYPI20050870A 2004-03-05 2005-03-03 Crystalline composition containing escitalopram. MY142756A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200400382 2004-03-05

Publications (1)

Publication Number Publication Date
MY142756A true MY142756A (en) 2010-12-31

Family

ID=36607154

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20050870A MY142756A (en) 2004-03-05 2005-03-03 Crystalline composition containing escitalopram.

Country Status (9)

Country Link
KR (1) KR20060126587A (zh)
CN (3) CN101492436A (zh)
AR (1) AR047749A1 (zh)
IL (1) IL177504A0 (zh)
MY (1) MY142756A (zh)
PE (1) PE20051162A1 (zh)
SG (1) SG159504A1 (zh)
TW (1) TW200605916A (zh)
ZA (1) ZA200607382B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114763343A (zh) * 2021-01-14 2022-07-19 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法
CN113663356B (zh) * 2021-08-23 2022-09-23 广西埃索凯新材料科技有限公司 一种应用于硫酸锰生产的结晶除杂监控系统

Also Published As

Publication number Publication date
SG159504A1 (en) 2010-03-30
AR047749A1 (es) 2006-02-15
CN1925844A (zh) 2007-03-07
IL177504A0 (en) 2006-12-10
CN101492436A (zh) 2009-07-29
CN101492435A (zh) 2009-07-29
ZA200607382B (en) 2008-05-28
TW200605916A (en) 2006-02-16
KR20060126587A (ko) 2006-12-07
PE20051162A1 (es) 2006-01-16

Similar Documents

Publication Publication Date Title
TW200519075A (en) Novel compounds
BR0206164A (pt) Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
WO2004014322A3 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
TW200510301A (en) Novel compounds
GEP20074030B (en) Controlled synthesis of ziprasidone and compositions thereof
ME01394B (me) Kristalni oblik gama-d ivabradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže
MXPA04004956A (es) Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central.
AU2002326072A1 (en) Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
WO2010131922A3 (en) Amide compound, preparation method thereof and pharmaceutical composition comprising same
UA96308C2 (ru) Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение
WO2006002140A3 (en) Compositions comprising amphotericin b
WO2011065800A3 (ko) 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
MXPA04003858A (es) Antagonistas de mch para el tratamiento de obesidad.
HK1102427A1 (en) Compositions comprising strontium and vitamin d and uses thereof
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
WO2008102321A3 (en) Oral polyphosphate compositions
UA95088C2 (ru) Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1126194A1 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
MY137846A (en) Processes for the preparation of oral dosage formulations of modafinil
EA200601641A1 (ru) Кристаллическая композиция, содержащая оксалат эсциталопрама
MY142756A (en) Crystalline composition containing escitalopram.